Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease: A Randomized Placebo-Controlled Clinical Trial.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: June 10, 2020
An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension.
Journal: Diabetologia
Published: August 07, 2019
A Randomized, Placebo-Controlled, Multiple-Ascending-Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Soluble Guanylate Cyclase Stimulator Praliciguat in Healthy Subjects.
Journal: Clinical pharmacology in drug development
Published: May 04, 2018
Efficacy and safety of inhaled calcium lactate PUR118 in the ozone challenge model--a clinical trial.
Journal: BMC pharmacology & toxicology
Published: March 13, 2015
The effects of an epithelial barrier protective cationic aerosol on allergen-induced airway inflammation in asthma: a randomized, placebo-controlled clinical trial.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: June 10, 2014
A genome-wide association study of bronchodilator response in asthmatics.
Journal: The pharmacogenomics journal
Published: June 25, 2012
A polymorphism in the thyroid hormone receptor gene is associated with bronchodilator response in asthmatics.
Journal: The pharmacogenomics journal
Published: January 04, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026